Portfolio

ProArc Medical

Minimally invasive solution for enlarged prostate (BPH)

Technology Development

Business Development

Revenue

Exited

Founded

2010

CEO
Gilad Hizkiyahu
UN SDGs
3
Contact Us
email
Follow Us
linkedin
Investors
The Trendlines Group, the Israel Innovation Authority, Horizon 2020

About

The Omega solution by ProArc Medical is a minimally invasive procedure that restores urinary function and immediately relieves Lower Urinary Tract Symptoms (LUTS) caused by an enlarged prostate – Benign Prostatic Hyperplasia (BPH)

Omega is a non-surgical procedure offering long term efficacy at a reduced risk.

Market Need

BPH, or enlarged prostate, is a noncancerous growth of the cells within the prostate gland. A common condition, BPH affects about 50% of men over the age of 50 and 80% over the age of 80. Symptoms include a weak or slow urinary stream, a feeling of incomplete bladder emptying, delay in starting urination, frequent urination, and urinary urgency.

Traditionally, BPH symptoms have been treated with medication or with invasive surgery such as prostatectomy. These treatment options have numerous shortcomings.

Skip to content